ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Cancer Diagnosis and Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35S9798
Home | Market Reports | Health| Men s Health
Global Prostate Cancer Diagnosis and Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Prostate Cancer Diagnosis and Treatment Market Research Report 2025

Code: QYRE-Auto-35S9798
Report
September 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
AbbVie
Active Biotech
Amgen Inc
Astellas Pharma
Astrazeneca plc
Bavarian Nordic
Bayer
Bristol–Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen S A
Johnson & Johnson
Pfizer Inc
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals

Prostate Cancer Diagnosis and Treatment Market

The global market for Prostate Cancer Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Prostate Cancer Diagnosis and Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prostate Cancer Diagnosis and Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prostate Cancer Diagnosis and Treatment in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prostate Cancer Diagnosis and Treatment include Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer, Bristol-Myers Squibb, Dendreon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnosis and Treatment.
The Prostate Cancer Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Prostate Cancer Diagnosis and Treatment Market Report

Report Metric Details
Report Name Prostate Cancer Diagnosis and Treatment Market
Segment by Type
  • Prostate Specific Antigen Test (PSA)
  • Digital Rectal Exam (DRE)
Segment by Application
  • Hospitals
  • Diagnostic clinics
  • Research centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer, Bristol-Myers Squibb, Dendreon, Endo, Ferring Pharmaceuticals, GE Healthcare, GSK, Ipsen, Johnson & Johnson, Pfizer, Sanofi, Siemens Healthineers, Takeda, Teva Pharmaceutical, Tolmar Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prostate Cancer Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prostate Cancer Diagnosis and Treatment Market report?

Ans: The main players in the Prostate Cancer Diagnosis and Treatment Market are Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer, Bristol-Myers Squibb, Dendreon, Endo, Ferring Pharmaceuticals, GE Healthcare, GSK, Ipsen, Johnson & Johnson, Pfizer, Sanofi, Siemens Healthineers, Takeda, Teva Pharmaceutical, Tolmar Pharmaceuticals

What are the Application segmentation covered in the Prostate Cancer Diagnosis and Treatment Market report?

Ans: The Applications covered in the Prostate Cancer Diagnosis and Treatment Market report are Hospitals, Diagnostic clinics, Research centers

What are the Type segmentation covered in the Prostate Cancer Diagnosis and Treatment Market report?

Ans: The Types covered in the Prostate Cancer Diagnosis and Treatment Market report are Prostate Specific Antigen Test (PSA), Digital Rectal Exam (DRE)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prostate Specific Antigen Test (PSA)
1.2.3 Digital Rectal Exam (DRE)
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2020-2031)
2.2 Global Prostate Cancer Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Diagnosis and Treatment Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Treatment Industry Trends
2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers
2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges
2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Diagnosis and Treatment Revenue
3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2024
3.5 Global Key Players of Prostate Cancer Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Prostate Cancer Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Prostate Cancer Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2020-2031)
6.2 North America Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2020-2031)
7.2 Europe Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2020-2031)
9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Active Biotech
11.3.1 Active Biotech Company Details
11.3.2 Active Biotech Business Overview
11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.3.5 Active Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.5.5 Astellas Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Details
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.7.5 Bavarian Nordic Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Dendreon
11.10.1 Dendreon Company Details
11.10.2 Dendreon Business Overview
11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.10.5 Dendreon Recent Development
11.11 Endo
11.11.1 Endo Company Details
11.11.2 Endo Business Overview
11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.11.5 Endo Recent Development
11.12 Ferring Pharmaceuticals
11.12.1 Ferring Pharmaceuticals Company Details
11.12.2 Ferring Pharmaceuticals Business Overview
11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.12.5 Ferring Pharmaceuticals Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.13.5 GE Healthcare Recent Development
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.14.5 GSK Recent Development
11.15 Ipsen
11.15.1 Ipsen Company Details
11.15.2 Ipsen Business Overview
11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.15.5 Ipsen Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Details
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.16.5 Johnson & Johnson Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.17.5 Pfizer Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Details
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.18.5 Sanofi Recent Development
11.19 Siemens Healthineers
11.19.1 Siemens Healthineers Company Details
11.19.2 Siemens Healthineers Business Overview
11.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
11.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.19.5 Siemens Healthineers Recent Development
11.20 Takeda
11.20.1 Takeda Company Details
11.20.2 Takeda Business Overview
11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.20.5 Takeda Recent Development
11.21 Teva Pharmaceutical
11.21.1 Teva Pharmaceutical Company Details
11.21.2 Teva Pharmaceutical Business Overview
11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.21.5 Teva Pharmaceutical Recent Development
11.22 Tolmar Pharmaceuticals
11.22.1 Tolmar Pharmaceuticals Company Details
11.22.2 Tolmar Pharmaceuticals Business Overview
11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
11.22.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
AbbVie
Active Biotech
Amgen Inc
Astellas Pharma
Astrazeneca plc
Bavarian Nordic
Bayer
Bristol–Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen S A
Johnson & Johnson
Pfizer Inc
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals
List of Tables
 Table 1. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prostate Specific Antigen Test (PSA)
 Table 3. Key Players of Digital Rectal Exam (DRE)
 Table 4. Global Prostate Cancer Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Prostate Cancer Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Prostate Cancer Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Prostate Cancer Diagnosis and Treatment Market Share by Region (2020-2025)
 Table 8. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Prostate Cancer Diagnosis and Treatment Market Share by Region (2026-2031)
 Table 10. Prostate Cancer Diagnosis and Treatment Market Trends
 Table 11. Prostate Cancer Diagnosis and Treatment Market Drivers
 Table 12. Prostate Cancer Diagnosis and Treatment Market Challenges
 Table 13. Prostate Cancer Diagnosis and Treatment Market Restraints
 Table 14. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Prostate Cancer Diagnosis and Treatment Market Share by Players (2020-2025)
 Table 16. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2024)
 Table 17. Ranking of Global Top Prostate Cancer Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Prostate Cancer Diagnosis and Treatment, Headquarters and Area Served
 Table 20. Global Key Players of Prostate Cancer Diagnosis and Treatment, Product and Application
 Table 21. Global Key Players of Prostate Cancer Diagnosis and Treatment, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2020-2025)
 Table 25. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2026-2031)
 Table 27. Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2020-2025)
 Table 29. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2026-2031)
 Table 31. North America Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product
 Table 49. Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. AbbVie Company Details
 Table 52. AbbVie Business Overview
 Table 53. AbbVie Prostate Cancer Diagnosis and Treatment Product
 Table 54. AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 55. AbbVie Recent Development
 Table 56. Active Biotech Company Details
 Table 57. Active Biotech Business Overview
 Table 58. Active Biotech Prostate Cancer Diagnosis and Treatment Product
 Table 59. Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 60. Active Biotech Recent Development
 Table 61. Amgen Company Details
 Table 62. Amgen Business Overview
 Table 63. Amgen Prostate Cancer Diagnosis and Treatment Product
 Table 64. Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 65. Amgen Recent Development
 Table 66. Astellas Pharma Company Details
 Table 67. Astellas Pharma Business Overview
 Table 68. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product
 Table 69. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 70. Astellas Pharma Recent Development
 Table 71. AstraZeneca Company Details
 Table 72. AstraZeneca Business Overview
 Table 73. AstraZeneca Prostate Cancer Diagnosis and Treatment Product
 Table 74. AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 75. AstraZeneca Recent Development
 Table 76. Bavarian Nordic Company Details
 Table 77. Bavarian Nordic Business Overview
 Table 78. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product
 Table 79. Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 80. Bavarian Nordic Recent Development
 Table 81. Bayer Company Details
 Table 82. Bayer Business Overview
 Table 83. Bayer Prostate Cancer Diagnosis and Treatment Product
 Table 84. Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 85. Bayer Recent Development
 Table 86. Bristol-Myers Squibb Company Details
 Table 87. Bristol-Myers Squibb Business Overview
 Table 88. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product
 Table 89. Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 90. Bristol-Myers Squibb Recent Development
 Table 91. Dendreon Company Details
 Table 92. Dendreon Business Overview
 Table 93. Dendreon Prostate Cancer Diagnosis and Treatment Product
 Table 94. Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 95. Dendreon Recent Development
 Table 96. Endo Company Details
 Table 97. Endo Business Overview
 Table 98. Endo Prostate Cancer Diagnosis and Treatment Product
 Table 99. Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 100. Endo Recent Development
 Table 101. Ferring Pharmaceuticals Company Details
 Table 102. Ferring Pharmaceuticals Business Overview
 Table 103. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product
 Table 104. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 105. Ferring Pharmaceuticals Recent Development
 Table 106. GE Healthcare Company Details
 Table 107. GE Healthcare Business Overview
 Table 108. GE Healthcare Prostate Cancer Diagnosis and Treatment Product
 Table 109. GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 110. GE Healthcare Recent Development
 Table 111. GSK Company Details
 Table 112. GSK Business Overview
 Table 113. GSK Prostate Cancer Diagnosis and Treatment Product
 Table 114. GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 115. GSK Recent Development
 Table 116. Ipsen Company Details
 Table 117. Ipsen Business Overview
 Table 118. Ipsen Prostate Cancer Diagnosis and Treatment Product
 Table 119. Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 120. Ipsen Recent Development
 Table 121. Johnson & Johnson Company Details
 Table 122. Johnson & Johnson Business Overview
 Table 123. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product
 Table 124. Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 125. Johnson & Johnson Recent Development
 Table 126. Pfizer Company Details
 Table 127. Pfizer Business Overview
 Table 128. Pfizer Prostate Cancer Diagnosis and Treatment Product
 Table 129. Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 130. Pfizer Recent Development
 Table 131. Sanofi Company Details
 Table 132. Sanofi Business Overview
 Table 133. Sanofi Prostate Cancer Diagnosis and Treatment Product
 Table 134. Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 135. Sanofi Recent Development
 Table 136. Siemens Healthineers Company Details
 Table 137. Siemens Healthineers Business Overview
 Table 138. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product
 Table 139. Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 140. Siemens Healthineers Recent Development
 Table 141. Takeda Company Details
 Table 142. Takeda Business Overview
 Table 143. Takeda Prostate Cancer Diagnosis and Treatment Product
 Table 144. Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 145. Takeda Recent Development
 Table 146. Teva Pharmaceutical Company Details
 Table 147. Teva Pharmaceutical Business Overview
 Table 148. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product
 Table 149. Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 150. Teva Pharmaceutical Recent Development
 Table 151. Tolmar Pharmaceuticals Company Details
 Table 152. Tolmar Pharmaceuticals Business Overview
 Table 153. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product
 Table 154. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2020-2025) & (US$ Million)
 Table 155. Tolmar Pharmaceuticals Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Prostate Cancer Diagnosis and Treatment Picture
 Figure 2. Global Prostate Cancer Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostate Cancer Diagnosis and Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Prostate Specific Antigen Test (PSA) Features
 Figure 5. Digital Rectal Exam (DRE) Features
 Figure 6. Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Diagnostic clinics Case Studies
 Figure 10. Research centers Case Studies
 Figure 11. Prostate Cancer Diagnosis and Treatment Report Years Considered
 Figure 12. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Prostate Cancer Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Prostate Cancer Diagnosis and Treatment Market Share by Region: 2024 VS 2031
 Figure 15. Global Prostate Cancer Diagnosis and Treatment Market Share by Players in 2024
 Figure 16. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2024
 Figure 18. North America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Prostate Cancer Diagnosis and Treatment Market Share by Country (2020-2031)
 Figure 20. United States Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Prostate Cancer Diagnosis and Treatment Market Share by Country (2020-2031)
 Figure 24. Germany Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Region (2020-2031)
 Figure 32. China Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Country (2020-2031)
 Figure 40. Mexico Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Country (2020-2031)
 Figure 44. Turkey Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 48. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 49. Active Biotech Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 50. Amgen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 51. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 53. Bavarian Nordic Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 54. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 56. Dendreon Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 57. Endo Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 58. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 59. GE Healthcare Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 60. GSK Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 61. Ipsen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 62. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 63. Pfizer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 64. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 65. Siemens Healthineers Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 66. Takeda Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 67. Teva Pharmaceutical Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 68. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions